# Nath Bio-Genes (India) Ltd (NATHBIOGEN)
> Exchange: NSE | Sector: Chemicals | ISIN: INE448G01010

## Price
Current Price: ₹172.83
Day Change: +1.35%
52W High: ₹238.69
52W Low: ₹126.15
Market Cap: ₹305 Cr

## Valuation
P/E: 7.64
P/B: 0.46
EPS: ₹20.97
Book Value: ₹345.69
Dividend Yield: 1.26%

## Returns
1Y Return: -6.33%

## Profitability
ROE: 6.29%
ROCE: 8.97%
Debt/Equity: 0.2
Revenue Growth: -1%
Profit Growth: 0%
EBITDA Margin: 11.78%
Operating Margin: 6.69%

## About
Nath Bio-Genes (India) Ltd is a Agricultural Inputs company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Chemicals
Industry: Agricultural Inputs
Sub Industry: Unknown

## Business Model
Overview: Nath Bio-Genes (India) Ltd makes money through Manufactured commodity sales, Value-added products, Exports or institutional demand in Agricultural Inputs. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Chemicals.
Source: Derived from stock data
Revenue Streams:
- Manufactured commodity sales
- Value-added products
- Exports or institutional demand
Operating Model:
- Uses plants, mines, or processing assets to convert raw materials into industrial products.
- Realisation, utilisation, energy cost, logistics, and commodity cycles drive earnings.
Recent Context:
- Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- Concall Transcript: NBIL Concall
- BSE Filing: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

## Access
Current tier: anonymous
More history: Register free to see 7 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:13.396Z
Price History Updated: 2026-05-18T22:59:30.656Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:30.656Z
Quant Updated: 2026-05-18T22:59:30.656Z
Sentiment Updated: 2026-05-18T22:59:30.656Z
Financials Status: current
Financials Updated: 2026-05-19T14:30:12.419Z
Financials Last Attempt: 2026-05-19T14:30:12.419Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹364.91 Cr
Operating Profit: ₹47.49 Cr (OPM 13.01%)
Net Profit: ₹38.6 Cr
Tax: ₹1.98 Cr

## Annual P&L History
FY25: Rev ₹364.91Cr | PAT ₹38.6Cr | OPM 13.01%
FY24: Rev ₹332.62Cr | PAT ₹39.62Cr | OPM 14.08%
FY23: Rev ₹301.36Cr | PAT ₹35.01Cr | OPM 15.28%

## Balance Sheet (FY25)
Total Assets: ₹1026.21 Cr
Total Liabilities: ₹381.82 Cr
Borrowings: ₹122.5 Cr
Cash: ₹88.53 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Satish  Kagliwal, Executive Chairman & MD
- Amol Arunrao Gupta, Chief Financial Officer
- Dhiraj Rajesh Rathi, Company Secretary & Compliance Officer
- Harish B. Pandey, Vice President of Marketing
- Devinder Gurusharan Khurana, Executive Vice President

---
Source: rupiya.io/stocks/nathbiogen
Disclaimer: For research and education only. Not investment advice.